Pharmacokinetic Considerations regarding Tigecycline for Multidrug-Resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii Urosepsis-Reference-Cited by-同舟云学术

Pharmacokinetic Considerations regarding Tigecycline for Multidrug-Resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii Urosepsis

Published:2009-05 Issue:5 Volume:47 Page:1613-1613
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Cunha Burke A.¹

Affiliation:

1. Infectious Disease Division  Winthrop-University Hospital  Mineola, New York 11501

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00404-09

Reference12 articles.

1. Agwuh, K. N., and A. MacGowan. 2006. Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J. Antimicrob. Chemother.58:256-265.

2. Cunha, B. A. 2007. Once-daily tigecycline therapy of multidrug-resistant and non-multidrug resistant gram-negative bacteremias. J. Chemother.19:232-233.

3. Antibiotic essentials 2009

4. Cunha, B. A., P. D. Domenico, and C. B. Cunha. 2005. Pharmacodynamics of doxycycline. Clin. Microbiol. Infect. Dis.52:163-164.

5. Cunha, B. A., B. McDermott, and S. Nausheen. 2008. Single daily high-dose tigecycline therapy of a multidrug-resistant (MDR) Klebsiella pneumoniae and Enterobacter aerogenes nosocomial urinary tract infection. J. Chemother.19:753-754.

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dirençli Gram-Negatif Bakteri İnfeksiyonlarının Yönetiminde Sık Karşılaşılan Sorunlar ve Çözüm Önerileri: Klinik Pratiğe Yönelik Uzman Görüş;Flora the Journal of Infectious Diseases and Clinical Microbiology;2024-03-22

2. Current and Emerging Treatment Options for Multidrug Resistant Escherichia coli Urosepsis: A Review;Antibiotics;2022-12-15

3. Answers to the authors of the “Letter to the Editor”: A comparative study between non colistin based combinations for treatment of infections caused by extensive drug resistant Acinetobacter baumannii: comments;International Journal of Clinical Pharmacy;2021-01-07

4. Tigecycline: A rescue drug for multi-drug resistant organisms causing urinary tract infection;Journal of Clinical Urology;2020-06-10

5. Clinical study on the safety and efficacy of high-dose tigecycline in the elderly patients with multidrug-resistant bacterial infections;Medicine;2020-03